Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Colorectal Neoplasms

Free Subscription Articles published in Ann Oncol Retrieve available abstracts of 45 articles: HTML format Text format

Single Articles

January 2012
1. SANTINI D , Tampellini M, Vincenzi B, Ibrahim T, et al
   Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study.
   Ann Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. STINTZING S , Fischer von Weikersthal L, Decker T, Vehling-Kaiser U, et al
   FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306.
   Ann Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. SCARTOZZI M , Giampieri R, Maccaroni E, Mandolesi A, et al
   Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.
   Ann Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. HENDLISZ A , Golfinopoulos V, Garcia C, Covas A, et al
   Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.
   Ann Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. BUYSE M , Sargent DJ, Goldberg RM, de Gramont A, et al
   The ARCAD advanced colorectal cancer database--open for business.
   Ann Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
6. BARBA M , Sperati F, Stranges S, Carlomagno C, et al
   Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.
   Ann Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. PINTO C , Di Fabio F, Maiello E, Pini S, et al
   Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).
   Ann Oncol. 2011;22:2424-30.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
8. MAO C , Yang ZY, Hu XF, Chen Q, et al
   PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
   Ann Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. PRICE TJ , Zannino D, Wilson K, Simes RJ, et al
   Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C.
   Ann Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. CEN P , Liu C, Du XL
    Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. KLAVER YL , Lemmens VE, Creemers GJ, Rutten HJ, et al
    Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy.
    Ann Oncol. 2011;22:2250-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
12. HUH JW , Jeong YY, Kim HR, Kim YJ, et al
    Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. ZHANG RX , Wu XJ, Wan DS, Lu ZH, et al
    Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. CREA F , Fornaro L, Paolicchi E, Masi G, et al
    An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. TWELVES C , Scheithauer W, McKendrick J, Seitz JF, et al
    Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. WONG R , Cunningham D, Barbachano Y, Saffery C, et al
    A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.
    Ann Oncol. 2011;22:2042-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
17. SUZUKI C , Blomqvist L, Sundin A, Jacobsson H, et al
    The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. KATO T , Muro K, Yamaguchi K, Bando H, et al
    Cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer: results from the randomised phase II part of a phase I/II study.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. MALKA D , Boige V, Jacques N, Vimond N, et al
    Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CHANG HJ , Lee KW, Kim JH, Bang SM, et al
    Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. FORMICA V , Martano L, Palmirotta R, Ferroni P, et al
    VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea.
    Ann Oncol. 2011;22:1928-9.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
22. RUSSO A , Rizzo S
    Biomarkers and efficacy: are we nearly there yet?
    Ann Oncol. 2011;22:1469-70.
    PubMed     Text format     Related articles   
    
    
    
    
23. LYRATZOPOULOS G , Barbiere JM, Rachet B, Baum M, et al
    Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care.
    Ann Oncol. 2011;22:1661-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
24. MASUDA S
    Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. CHU D , Zhang Z, Li Y, Ji G, et al
    Reply to Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
26. CHAMBERS P , Daniels SH, Thompson LC, Stephens RJ, et al
    Chemotherapy dose reductions in obese patients with colorectal cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. GAZZANIGA P , Raimondi C, Gradilone A, Di Seri M, et al
    Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
28. AUNE D , Lau R, Chan DS, Vieira R, et al
    Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. MATSUO K , Mizoue T, Tanaka K, Tsuji I, et al
    Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in Japan.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
30. CATALANO V , Loupakis F, Graziano F, Bisonni R, et al
    Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
31. TRAA MJ , De Vries J, Roukema JA, Den Oudsten BL, et al
    Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic review.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. RIVERA B , Gonzalez S, Sanchez-Tome E, Blanco I, et al
    Clinical and genetic characterization of classical forms of familial adenomatous polyposis: a Spanish population study.
    Ann Oncol. 2011;22:903-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
33. STARLING N , Vazquez-Mazon F, Cunningham D, Chau I, et al
    A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. WINDER T , Bohanes P, Zhang W, Yang D, et al
    GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. CHU D , Zhang Z, Zhou Y, Wang W, et al
    Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. MARTONI AA , Di Fabio F, Pinto C, Castellucci P, et al
    Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer.
    Ann Oncol. 2011;22:650-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
37. FEDIRKO V , Tramacere I, Bagnardi V, Rota M, et al
    Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. ZHANG W , Labonte MJ, Lenz HJ
    KRAS let-7 LCS6 SNP predicts cetuximab efficacy in KRASwt metastatic colorectal cancer patients: Does treatment combination partner matter?
    Ann Oncol. 2011;22:484-5.
    PubMed     Text format     Related articles   
    
    
    
    
39. RESCH G , Schaberl-Moser R, Kier P, Kopetzky G, et al
    Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe.
    Ann Oncol. 2011;22:486-7.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
40. LI X , Butts C, Fenton D, King K, et al
    Utilization of oncology services and receipt of treatment: a comparison between patients with breast, colon, rectal, or lung cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. TEBBUTT NC , Murphy F, Zannino D, Wilson K, et al
    Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. BOKEMEYER C , Bondarenko I, Hartmann JT, de Braud F, et al
    Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
43. BUJKO K , Glynne-Jones R, Bujko M
    Adjuvant chemotherapy for rectal cancer.
    Ann Oncol. 2010;21:2443.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
44. CHUA TC , Sarkar A, Saxena A, Glenn D, et al
    Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients.
    Ann Oncol. 2010;21:2017-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
45. PARMELLI E , Papini D, Moja L, Bandieri E, et al
    Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance.
    Ann Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: